NASDAQ · GSIW
Garden Stage Limited financials
$10.80−16.92%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '26 Mar 31 | Q4 '25 Mar 31 | Q4 '24 Mar 31 |
|---|---|---|---|
| Revenue | — | — | — |
| Gross profit | — | — | — |
| Gross margin | — | — | — |
| Operating income | — | — | — |
| Net income | — | — | — |
| Net margin | — | — | — |
| Diluted EPS | — | — | — |
| EBITDA | $0.00 | $0.00 | $0.00 |
| Operating cash flow | — | — | — |
| Free cash flow | — | — | — |
| Diluted shares | 10.0M | 9.3M | 9.3M |
Balance sheet
| Period end | Mar 31 | Mar 31 | Mar 31 |
|---|---|---|---|
| Cash & equivalents | $6.8M | $624.6K | $2.7M |
| Short-term investments | $31.1K | $0.00 | $0.00 |
| Total debt | $15.5M | $8.0M | $6.1M |
| Total assets | $41.9M | $15.9M | $16.6M |
| Total liabilities | $17.7M | $9.2M | $7.3M |
| Shareholders' equity | $24.2M | $6.7M | $9.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology